VRAX

Virax Biolabs Group Ltd

0.2439

+0.0904+58.89%

Opening15:25 05/18 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.3000/0.1535

TODAY RANGE0.2250-0.5335

VOL749.29M

MARKET CAP4.86M

52 WEEK RANGE0.1000-1.200

AVG VOL (3M)13.70M

% TURNOVER3,760.86%

TURNOVER--

P/E (TTM)-0.1952

% RANGE200.98%

EPS(TTM)-1.2495

P/E(FORWARD)-0.6098

P/B0.3004

BVPS0.8118

DIVIDEND--

P/S162.60

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.77M

SHARES OUTSTANDING19.92M

NEXT EARNINGS--

FREE FLOAT19.57M

LOT SIZE1

EX-DATE12/18/2023

News

Press Releases

Financial Reports

Profile

NASDAQ·04/14 15:13
Virax CEO Foster Releases Shareholder Letter Regarding Upcoming Milestones
TipRanks·04/14 13:00
Virax Biolabs CEO Sets Near-Term Milestones as ViraxImmune Strategy Advances and Valuation Lags
PUBT·04/14 12:44
Virax Biolabs publishes updated Q2 2026 investor presentation and factsheet
TipRanks·04/14 11:58
Virax Biolabs CEO outlines strategic priorities, near-term milestones
PUBT·04/14 11:34
Virax Biolabs announces availability of shareholder letter from CEO James Foster
Reuters·04/14 11:34
VIRAX BIOLABS' CEO JAMES FOSTER OUTLINES STRATEGIC PRIORITIES AND NEAR-TERM MILESTONES IN LETTER TO SHAREHOLDERS
NASDAQ·04/13 10:47
Stocks To Watch Today: IDYA, OGN, VRX, REPL...
TipRanks·04/10 20:57
Virax Biolabs Announces Full Exercise of Pre-Funded Warrants From $5 Million Private Placement
Reuters·04/10 20:16
Virax Biolabs raises $5 million in private placement via pre-funded warrants, options
Reuters·04/01 01:37
Virax Biolabs director Nelson Haight files initial beneficial ownership statement
Reuters·03/20 14:43
Virax Biolabs Group Ltd. COO and Director Nigel William McCracken files initial beneficial ownership statement
TipRanks·03/18 22:00
Virax Biolabs Shareholders Approve Reverse Split, New Charter and 2026 Equity Plan After Adjourned AGM
Reuters·03/18 21:09
Virax Biolabs Delays 2025 Annual Shareholder Meeting After Failing to Reach Quorum, Reschedules for March 18, 2026
Reuters·03/18 20:08
Virax Biolabs Group names director Evan Michael Norton in initial beneficial ownership filing
Reuters·03/18 20:08
Virax Biolabs CEO Foster James Alexander Cunliffe Files Initial Beneficial Ownership Statement

Same Industry

Name/Symbol

Change%

Price

VRAX

Regeneron Pharmaceuticals

REGN

-2.05%

698.25

GRDX

BIONTECH

BNTX

-2.65%

89.55

UTHR

Siga Technologie

SIGA

-2.11%

4.170

VRTX

MRNA

Charles Riv Labs Intl Inc

CRL

-5.20%

150.85

MEDP

Talphera Inc

TLPH

-5.52%

0.8480

China Biologic

CBPO

0.00%

119.99

ICON PLC

ICLR

-0.61%

116.38

IQV

MOLN

PRA Health

PRAH

0.00%

165.21

Arcturus Therape

ARCT

-4.60%

7.47

GILD

APVO

Incyte Corp

INCY

-2.38%

95.31

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.